NCT05191706 - Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

February 28, 2026

Conditions

Cataract

Interventions

DRUG

Dexamethasone

single anterior chamber injection

DRUG

Prednisolone Acetate Ophthalmic

topical administration four times a day for 28 days, followed by treatment taper

Trial Locations (9)

RECRUITING

EyePoint Investigative Site, New York

RECRUITING

EyePoint Investigational Site, Buffalo

RECRUITING

EyePoint Investigational Site, Rochester

RECRUITING

EyePoint Investigational Site, Charleston

RECRUITING

EyePoint Investigational Site, Jackson

RECRUITING

EyePoint Investigational Site, Omaha

RECRUITING

EyePoint Investigational Site, Huntington Beach

ACTIVE_NOT_RECRUITING

EyePoint Investigational Site, Palo Alto

RECRUITING

EyePoint Investigative Site, Boston